InsiderTrades.com logo
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals   |   Ad
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.
Remy Sukhija net worth and biography
  • Phone
  • Email
  • Website

Remy Sukhija Biography and Net Worth

Sr. VP & Chief Commercial Officer of Madrigal Pharmaceuticals
Remy Sukhija is the Sr. VP & Chief Commercial Officer at Madrigal Pharmaceuticals Inc.

How do I contact Remy Sukhija?

The corporate mailing address for Mr. Sukhija and other Madrigal Pharmaceuticals executives is 200 BARR HARBOR DRIVE SUITE 400, WEST CONSHOHOCKEN PA, 19428. Madrigal Pharmaceuticals can also be reached via phone at (267) 824-2827 and via email at [email protected]. Learn More on Remy Sukhija's contact information.

Has Remy Sukhija been buying or selling shares of Madrigal Pharmaceuticals?

Remy Sukhija has not been actively trading shares of Madrigal Pharmaceuticals over the course of the past ninety days. Most recently, Remy Sukhija sold 30,000 shares of the business's stock in a transaction on Friday, December 23rd. The shares were sold at an average price of $274.14, for a transaction totalling $8,224,200.00. Learn More on Remy Sukhija's trading history.

Who are Madrigal Pharmaceuticals' active insiders?

Madrigal Pharmaceuticals' insider roster includes Richard Levy (Director), Brian Lynch (SVP), Remy Sukhija (Sr. VP & Chief Commercial Officer), and Robert Waltermire (VP). Learn More on Madrigal Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Madrigal Pharmaceuticals?

During the last twelve months, Madrigal Pharmaceuticals insiders bought shares 4 times. They purchased a total of 226,067 shares worth more than $43,382,043.47. During the last twelve months, insiders at the biopharmaceutical company sold shares 10 times. They sold a total of 154,796 shares worth more than $33,116,646.13. The most recent insider tranaction occured on April, 8th when CMO Rebecca Taub sold 2,676 shares worth more than $658,269.24. Insiders at Madrigal Pharmaceuticals own 23.9% of the company. Learn More about insider trades at Madrigal Pharmaceuticals.

Information on this page was last updated on 4/8/2024.

Remy Sukhija Insider Trading History at Madrigal Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2022Sell30,000$274.14$8,224,200.00View SEC Filing Icon  
See Full Table

Remy Sukhija Buying and Selling Activity at Madrigal Pharmaceuticals

This chart shows Remy Sukhija's buying and selling at Madrigal Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Madrigal Pharmaceuticals Company Overview

Madrigal Pharmaceuticals logo
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
Read More

Today's Range

Now: $193.33
Low: $189.00
High: $195.58

50 Day Range

MA: $243.29
Low: $193.33
High: $283.23

2 Week Range

Now: $193.33
Low: $119.76
High: $322.67

Volume

453,241 shs

Average Volume

529,518 shs

Market Capitalization

$3.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals   |   Ad
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.